Listed

Angiodynamics Inc: Form 10-Q for the period ended Nov 30, 2013

Filed with the SEC on Jan 9, 2014 and accepted by EDGAR at Jan 9, 2014, 16:35 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-11-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2013-09-01 to 2013-11-30$88.6mus-gaap:SalesRevenueNet
Revenue6 months2013-06-01 to 2013-11-30$172.2mus-gaap:SalesRevenueNet
Cost of revenue3 months2013-09-01 to 2013-11-30$43.7mus-gaap:CostOfGoodsSold
Cost of revenue6 months2013-06-01 to 2013-11-30$84.8mus-gaap:CostOfGoodsSold
Gross profit3 months2013-09-01 to 2013-11-30$44.9mus-gaap:GrossProfit
Gross profit6 months2013-06-01 to 2013-11-30$87.4mus-gaap:GrossProfit
Research and development3 months2013-09-01 to 2013-11-30$7.0mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2013-06-01 to 2013-11-30$13.7mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2013-09-01 to 2013-11-30$1.6mus-gaap:OperatingIncomeLoss
Operating income6 months2013-06-01 to 2013-11-30$2.9mus-gaap:OperatingIncomeLoss
Interest expense3 months2013-09-01 to 2013-11-30$959.0kus-gaap:InterestExpense
Interest expense6 months2013-06-01 to 2013-11-30$2.2mus-gaap:InterestExpense
Income tax3 months2013-09-01 to 2013-11-30$13.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2013-06-01 to 2013-11-30−$208.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2013-09-01 to 2013-11-30−$99.0kus-gaap:NetIncomeLoss
Net income6 months2013-06-01 to 2013-11-30−$525.0kus-gaap:NetIncomeLoss
Diluted EPS3 months2013-09-01 to 2013-11-30$0.00us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2013-06-01 to 2013-11-30−$0.01us-gaap:EarningsPerShareDiluted
Basic EPS3 months2013-09-01 to 2013-11-30$0.00us-gaap:EarningsPerShareBasic
Basic EPS6 months2013-06-01 to 2013-11-30−$0.01us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2013-09-01 to 2013-11-3035,132,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2013-06-01 to 2013-11-3035,041,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2013-06-01 to 2013-11-30$15.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2013-06-01 to 2013-11-30$7.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-11-30$15.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-11-30$141.6mus-gaap:AssetsCurrent
Total assetsAt period end2013-11-30$795.5mus-gaap:Assets
Current liabilitiesAt period end2013-11-30$69.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-11-30$265.8mus-gaap:Liabilities
Current portion of debtAt period end2013-11-30$5.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2013-11-30$529.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-14-006691. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.